Weave Communications, Inc. (WEAV)
NYSE: WEAV · Real-Time Price · USD
7.32
-0.01 (-0.14%)
At close: Sep 16, 2026, 4:00 PM EDT
7.34
+0.02 (0.27%)
Pre-market: Sep 17, 2026, 4:17 AM EDT
Weave Communications Revenue
Weave Communications had revenue of $67.54M in the quarter ending June 30, 2026, with 15.52% growth. This brings the company's revenue in the last twelve months to $257.79M, up 16.73% year-over-year. In the year 2025, Weave Communications had annual revenue of $239.02M with 16.99% growth.
Revenue (ttm)
$257.79M
Revenue Growth
+16.73%
P/S Ratio
2.27
Revenue / Employee
$285,163
Employees
904
Market Cap
585.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 239.02M | 34.71M | 16.99% |
| Dec 31, 2024 | 204.31M | 33.85M | 19.85% |
| Dec 31, 2023 | 170.47M | 28.35M | 19.95% |
| Dec 31, 2022 | 142.12M | 26.25M | 22.65% |
| Dec 31, 2021 | 115.87M | 35.98M | 45.03% |
| Dec 31, 2020 | 79.90M | 34.15M | 74.65% |
| Dec 31, 2019 | 45.75M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.49B |
| Evolent Health | 2.10B |
| Claritev | 994.67M |
| GoodRx Holdings | 785.23M |
| Phreesia | 507.79M |
| HealthStream | 321.12M |
| Omada Health | 309.76M |
| NRC Health | 140.00M |
WEAV News
- 1 day ago - Weave Communications Proxy statement: Proxy filing - Filings
- 7 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH) - GlobeNewsWire
- 15 days ago - Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities - Business Wire
- 23 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH) - GlobeNewsWire
- 24 days ago - Weave downgraded to Market Perform from Outperform at Raymond James - TheFly
- 27 days ago - Weave's 2026 Pulse Survey Finds Healthcare Practices Are Ready for AI, but 60% Are Still Concerned About Data Privacy - Business Wire
- 4 weeks ago - Halper Sadeh LLC is Investigating Whether WEAV and FULC are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 4 weeks ago - Weave downgraded to Neutral from Buy at B. Riley - TheFly